GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Shiller PE Ratio

Taiko Pharmaceutical Co (TSE:4574) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Taiko Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Taiko Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Shiller PE Ratio Chart

Taiko Pharmaceutical Co Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 27.82 65.22 63.88 -

Taiko Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Taiko Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiko Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's Shiller PE Ratio falls into.



Taiko Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Taiko Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Taiko Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.41/107.2000*107.2000
=9.410

Current CPI (Mar. 2024) = 107.2000.

Taiko Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 6.917 98.000 7.566
201409 11.367 98.500 12.371
201412 28.993 97.900 31.747
201503 -1.317 97.900 -1.442
201506 1.287 98.400 1.402
201509 1.840 98.500 2.003
201512 16.470 98.100 17.998
201603 1.673 97.900 1.832
201606 -0.903 98.100 -0.987
201609 7.207 98.000 7.884
201612 24.107 98.400 26.263
201703 -5.163 98.100 -5.642
201706 2.350 98.500 2.558
201709 4.140 98.800 4.492
201712 20.603 99.400 22.220
201803 -1.417 99.200 -1.531
201806 0.907 99.200 0.980
201809 9.550 99.900 10.248
201812 19.523 99.700 20.992
201903 2.977 99.700 3.201
201906 2.400 99.800 2.578
201909 12.650 100.100 13.547
201912 34.867 100.500 37.191
202003 7.423 100.300 7.934
202006 43.280 99.900 46.443
202009 22.670 99.900 24.327
202012 0.000 99.300 0.000
202103 -3.390 99.900 -3.638
202106 -51.230 99.500 -55.195
202109 9.781 100.100 10.475
202112 -175.730 100.100 -188.194
202203 -40.130 101.100 -42.551
202206 -24.093 101.800 -25.371
202209 -8.811 103.100 -9.161
202212 -39.311 104.100 -40.482
202303 -5.590 104.400 -5.740
202306 -5.770 105.200 -5.880
202309 -0.970 106.200 -0.979
202312 -64.160 106.800 -64.400
202403 9.410 107.200 9.410

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Taiko Pharmaceutical Co  (TSE:4574) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Taiko Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiko Pharmaceutical Co (TSE:4574) Business Description

Traded in Other Exchanges
N/A
Address
No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines